Lynn Marie Malec MD

PubMed

• Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies.
  Robert Klamroth, Annette von Drygalski, Cedric Hermans, Young-Shil Park, Anthony K C Chan
  Haemophilia. 2025-03-18
• 1 citations
  Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History.
  Mary Eapen, Lynn M Malec, Myriam A Armant, Bryon D Johnson, Qizhen Shi
  The New England Journal of Medicine. 2025-01-23
• Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.
  Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski, Kadhim Al Banaa, Jenny Y Zhou
  Blood Advances. 2024-11-26

Abstracts/Posters

• Von Willebrand Disease Minimize Menorrhagia (VWDMin) Trial
  Lynn M. Malec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Analysis of Bleeding and Treatment Patterns in Children and Adolescents before and after Von Willebrand Disease Diagnosis Using Data from a US Medical Claims Database
  Lynn M Malec, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019